Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
Oppenheimer is initiating coverage of Cepheid (NASDAQ: CPHD) with an Outperform rating and $33 target price.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
“Cepheid is a pure play molecular diagnostic company with a pioneering technology platform, the GeneXpert,” Oppenheimer writes. “Expansion of the testing menu with the launch of CT/NG and drug resistant tuberculosis tests, coupled with massive gross margin leverage from royalty payment expirations, are powerful near-term drivers.”
Cepheid closed today at $25.27.